KYTX Kyverna Therapeutics and elevatebio enter into commercial manufacturing and supply agreement for miv-cel Kyverna Therapeutics - agreeme
KYTX Kyverna Therapeutics and elevatebio enter into commercial manufacturing and supply agreement for miv-cel Kyverna Therapeutics - agreement provides scalable miv-cel supply for potential Sps and gmg launches - On track to complete rolling BLA submission for miv-cel in Sps in Q4 2026
Story updates
12:01:54 PM UTC
SquawkNews
KYTX - Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-celNew agreement secures flexible and scalable manufacturing to support the U.S. commercial and global clinical supply of miv-cel
KYTX Kyverna Therapeutics and elevatebio enter into commercial manufacturing and supply agreement for miv-cel Kyverna Therapeutics - agreement provides scalable miv-cel supply for potential Sps and gmg launches - On track to complete rolling BLA submission for miv-cel in Sps in Q4 2026